On June 5, 2023 Aravive, Inc. (Nasdaq: ARAV, "the Company"), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease reported that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and Rudy Howard, Chief Financial Officer will be presenting a corporate overview and participating in 1×1 meetings at the Jefferies Global Healthcare Conference being held on June 7-9, 2023 in New York, NY (Press release, Aravive, JUN 5, 2023, View Source [SID1234632458]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Global Healthcare Conference – June 7-9, 2023
Format: Aravive (ARAV) Company Presentation
Date/Time: Friday, June 9, 2023 at 8:30 AM EST
Session: Track 4
Presenter: Gail McIntyre, Ph.D., DABT, CEO, Aravive
Webcast: Registration Link – Click Here

A replay of the session will be available following the conference through the Aravive Events & Presentations section of the website View Source